BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34409854)

  • 1. The association of BMI and sarcopenia with survival in patients with glioblastoma multiforme.
    Guven DC; Aksun MS; Cakir IY; Kilickap S; Kertmen N
    Future Oncol; 2021 Nov; 17(32):4405-4413. PubMed ID: 34409854
    [No Abstract]   [Full Text] [Related]  

  • 2. The possible relation between temporal muscle mass and glioblastoma multiforme prognosis via sarcopenia perspective.
    Sütcüoğlu O; Erdal ZS; Akdoğan O; Çeltikçi E; Özdemir N; Özet A; Uçar M; Yazıcı O
    Turk J Med Sci; 2023 Feb; 53(1):413-419. PubMed ID: 36945944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is temporal muscle thickness a survival predictor in newly diagnosed glioblastoma multiforme?
    Yesil Cinkir H; Colakoglu Er H
    Asia Pac J Clin Oncol; 2020 Oct; 16(5):e223-e227. PubMed ID: 32762134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic relevance of temporal muscle thickness as a marker of sarcopenia in patients with glioblastoma at diagnosis.
    Muglia R; Simonelli M; Pessina F; Morenghi E; Navarria P; Persico P; Lorenzi E; Dipasquale A; Grimaldi M; Scorsetti M; Santoro A; Politi LS
    Eur Radiol; 2021 Jun; 31(6):4079-4086. PubMed ID: 33201284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal muscle thickness as an independent prognostic marker in glioblastoma patients-a systematic review and meta-analysis.
    Sadhwani N; Aggarwal A; Mishra A; Garg K
    Neurosurg Rev; 2022 Dec; 45(6):3619-3628. PubMed ID: 36350492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia and obesity among patients with soft tissue sarcoma - Association with clinicopathologic characteristics, complications and oncologic outcome: A systematic review and meta-analysis.
    Barnes ME; Elliott JA; McIntyre TV; Boyle EA; Gillis AE; Ridgway PF
    Eur J Surg Oncol; 2021 Sep; 47(9):2237-2247. PubMed ID: 34023166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between temporal muscle thickness and clinical outcomes in patients with newly diagnosed glioblastoma.
    An G; Ahn S; Park JS; Jeun SS; Hong YK
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):901-909. PubMed ID: 32929611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
    Furtner J; Genbrugge E; Gorlia T; Bendszus M; Nowosielski M; Golfinopoulos V; Weller M; van den Bent MJ; Wick W; Preusser M
    Neuro Oncol; 2019 Dec; 21(12):1587-1594. PubMed ID: 31369680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel.
    Cushen SJ; Power DG; Murphy KP; McDermott R; Griffin BT; Lim M; Daly L; MacEneaney P; O' Sullivan K; Prado CM; Ryan AM
    Clin Nutr ESPEN; 2016 Jun; 13():e39-e45. PubMed ID: 28531567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal Muscle Thickness as a Prognostic Marker in Patients with Newly Diagnosed Glioblastoma: Translational Imaging Analysis of the CENTRIC EORTC 26071-22072 and CORE Trials.
    Furtner J; Weller M; Weber M; Gorlia T; Nabors B; Reardon DA; Tonn JC; Stupp R; Preusser M;
    Clin Cancer Res; 2022 Jan; 28(1):129-136. PubMed ID: 34667022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of temporal muscle thickness, a novel radiographic marker of sarcopenia, in patients with brain tumor: A systematic review and meta-analysis.
    Yang YW; Ming Yang ; Zhou YW; Xia X; Jia SL; Zhao YL; Zhou LX; Cao Y; Ge ML
    Nutrition; 2023 Aug; 112():112077. PubMed ID: 37236042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases?
    Lodewick TM; van Nijnatten TJ; van Dam RM; van Mierlo K; Dello SA; Neumann UP; Olde Damink SW; Dejong CH
    HPB (Oxford); 2015 May; 17(5):438-46. PubMed ID: 25512239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel radiographic marker of sarcopenia with prognostic value in glioblastoma.
    Huq S; Khalafallah AM; Ruiz-Cardozo MA; Botros D; Oliveira LAP; Dux H; White T; Jimenez AE; Gujar SK; Sair HI; Pillai JJ; Mukherjee D
    Clin Neurol Neurosurg; 2021 Aug; 207():106782. PubMed ID: 34186275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
    Gruber ES; Jomrich G; Tamandl D; Gnant M; Schindl M; Sahora K
    PLoS One; 2019; 14(5):e0215915. PubMed ID: 31059520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between body mass index and mortality in patients with glioblastoma mutliforme.
    Jones LW; Ali-Osman F; Lipp E; Marcello JE; McCarthy B; McCoy L; Rice T; Wrensch M; Il'yasova D
    Cancer Causes Control; 2010 Dec; 21(12):2195-201. PubMed ID: 20838873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia and Sarcopenic Obesity in Patients Undergoing Orthopedic Surgery.
    Ji HM; Han J; Jin DS; Suh H; Chung YS; Won YY
    Clin Orthop Surg; 2016 Jun; 8(2):194-202. PubMed ID: 27247746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body mass index as an independent prognostic factor in glioblastoma.
    Valente Aguiar P; Carvalho B; Vaz R; Linhares P
    Cancer Causes Control; 2021 Apr; 32(4):327-336. PubMed ID: 33447892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Muscle and Adiposity Measured by Computed Tomography With Survival in Patients With Nonmetastatic Breast Cancer.
    Caan BJ; Cespedes Feliciano EM; Prado CM; Alexeeff S; Kroenke CH; Bradshaw P; Quesenberry CP; Weltzien EK; Castillo AL; Olobatuyi TA; Chen WY
    JAMA Oncol; 2018 Jun; 4(6):798-804. PubMed ID: 29621380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between pretreatment obesity, sarcopenia, and survival in patients with head and neck cancer.
    Fattouh M; Chang GY; Ow TJ; Shifteh K; Rosenblatt G; Patel VM; Smith RV; Prystowsky MB; Schlecht NF
    Head Neck; 2019 Mar; 41(3):707-714. PubMed ID: 30582237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of sarcopenia and myosteatosis on outcomes of unresectable pancreatic cancer or distal cholangiocarcinoma.
    Rollins KE; Tewari N; Ackner A; Awwad A; Madhusudan S; Macdonald IA; Fearon KC; Lobo DN
    Clin Nutr; 2016 Oct; 35(5):1103-9. PubMed ID: 26411749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.